ArticleJournal of the Endocrine Society2026
T cells are elevated in abdominal and femoral adipose tissue in females with type 2 diabetes.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- T cells are elevated in abdominal and femoral adipose tissue in females with type 2 diabetes.Journal of the Endocrine Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adipose tissue (AT) immune cells are implicated in the pathology of type 2 diabetes (T2D), and their content likely differs between abdominal subcutaneous adipose tissue (abSAT), femoral SAT (fmSAT), and visceral adipose tissue (VAT). Therefore, the objective of the current study was to develop an understanding of how immune cell presence differs between abSAT, fmSAT, and VAT depots in females who are lean (NO), have obesity (OB), or have OB + T2D. Premenopausal females were recruited from the community (NO, n = 14) or bariatric surgery clinics (OB, n = 10; OB + T2D, n = 8) in Montreal, Quebec, Canada. abSAT and fmSAT were obtained by needle aspiration biopsy in all participants, while VAT was excised from the OB and OB + T2D groups during surgery. AT immune cells were isolated from AT biopsies and stained for quantification via flow cytometry. OB + T2D fmSAT had a greater number of T cells (CD3+) than the NO group, with no difference between the NO and OB groups. We further found that abSAT CD3+, CD3+CD4+, CD3+CD8+, and CD68+CD206+ cells were greater in the OB + T2D group, followed by the OB group and then NO participants. There were no regional differences in T cells, macrophages, natural killer cells, or B cells between individuals with OB and OB + T2D. Our findings indicate that the importance of fmSAT and abSAT T cells in T2D pathogenesis should be further investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.